RT @stephensenn: One of my favourite but sadly negelected papers on the fallacy of 'representativeness' in clinical trials: https://t.co/1…

RT @stephensenn: One of my favourite but sadly negelected papers on the fallacy of 'representativeness' in clinical trials: https://t.co/1…

RT @stephensenn: One of my favourite but sadly negelected papers on the fallacy of 'representativeness' in clinical trials: https://t.co/1…

RT @stephensenn: One of my favourite but sadly negelected papers on the fallacy of 'representativeness' in clinical trials: https://t.co/1…

RT @stephensenn: One of my favourite but sadly negelected papers on the fallacy of 'representativeness' in clinical trials: https://t.co/1…

RT @stephensenn: One of my favourite but sadly negelected papers on the fallacy of 'representativeness' in clinical trials: https://t.co/1…

RT @stephensenn: One of my favourite but sadly negelected papers on the fallacy of 'representativeness' in clinical trials: https://t.co/1…

One of my favourite but sadly negelected papers on the fallacy of 'representativeness' in clinical trials: https://t.co/1Qp6bP9Px0 https://t.co/EKSsiNtugJ

RT @enriquegavilan Damos fármacos a ancianos pero en muchas ocasiones no se ha comprobado si son efectivos o seguros http://t.co/lCWSZj9E

“@enriquegavilan: . PlosMed http://t.co/qz4ffshT” ademas de no poder extrapolar los NNT, no

Sous-représentation des sujets agés dans les essais thérapeut. Bravo à l'équipe Ravaud ! (Et merci à @PUautomne) http://t.co/ekCcE6Wj

Un papier fort intéressant sur un vrai problème la sous représentation des sujets agés dans les essais thérapeutiques http://t.co/VL0bNNoF